The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor α

Advances in Enzyme Regulation

Volumn 44, Issue 1, 2004, Pages 75-92

  Willam, Carsten ^a   Nicholls, Lynn G ^a   Ratcliffe, Peter J ^a   Pugh, Christopher W ^a   Maxwell, Patrick H ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIOXYGENASE; DNA BINDING PROTEIN; EGLN3 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NUCLEAR PROTEIN; OXYGEN; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TRANSCRIPTION FACTOR;

ANIMAL; CONFERENCE PAPER; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIOXYGENASES; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASMS; NUCLEAR PROTEINS; OXYGEN; PROCOLLAGEN-PROLINE DIOXYGENASE; TRANSCRIPTION FACTORS;

EID: 9644283362     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2003.11.017     Document Type: Conference Paper

References (82)

1. Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A., Bunn H.F., Livingston D.M. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA. 93:1996;12969-12973
2. Berra E., Benizri E., Ginouves A., Volmat V., Roux D., Pouyssegur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22:2003;4082-4090
3. Berra E., Richard D.E., Gothie E., Pouyssegur J. HIF-1-dependent transcriptional activity is required for oxygen-mediated HIF-1alpha degradation. FEBS Lett. 491:2001;85-90
4. Bruick R.K., McKnight S.L. A conserved family of prolyl-4-Hydroxylases that modify HIF. Science. 294:2001;1337-1340
5. Carmeliet P., Dor Y., Herbert J.-.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P.H., Koch C.J., Ratcliffe P.J., Moons L., Jain R.K., Collen D., Keshet E. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 394:1998;485-490
6. Chan D.A., Sutphin P.D., Denko N.C., Giaccia A.J. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α J Biol Chem. 277:2002;40112-40117
7. Clifford S.C., Cockman M.E., Smallwood A.C., Mole D.R., Woodward E.R., Maxwell P.H., Ratcliffe P.J., Maher E.R. Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumorigenesis in von Hippel-Lindau disease. Hum Mol Genet. 10:2001;1029-1038
8. Conrad P.W., Freeman T.L., Beitner-Johnson D., Millhorn D.E. EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem. 274:1999;33709-33713
9. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., Firestein G.S., Gerber H.P., Ferrara N., Johnson R.S. HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 112:2003;645-657
10. D'Angelo G., Duplan E., Boyer N., Vigne P., Frelin C. Hypoxia up-regulates prolyl hydroxylase activity. a feedback mechanism that limits HIF-1 responses during reoxygenation J Biol Chem. 278:2003;38183-38187
11. Darby C., Cosma C.L., Thomas J.H., Manoil C. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc Natl Acad Sci USA. 96:1999;15202-15207
12. Dupuy D., Aubert I., Duperat V.G., Petit J., Taine L., Stef M., Bloch B., Arveiler B. Mapping, characterization, and expression analysis of the SM-20 human homologue, c1orf12, and identification of a novel related gene, SCAND2. Genomics. 69:2000;348-354
13. Ebert B.L., Bunn H.F. Regulation of the Erythropoietin Gene. Blood. 94:1999;1864-1877
14. Epstein A.C.R., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.-.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., Ratcliffe P.J. C. Elegans EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 107:2001;43-54
15. Erez N., Milyavsky M., Goldfinger N., Peles E., Gudkov A.V., Rotter V. Falkor, a novel cell growth regulator isolated by a functional genetic screen. Oncogene. 21:2002;6713-6721
16. Gallagher L.A., Manoil C. Pseudomonas aeruginosa PAO1 kills caenorhabditis elegans by cyanide poisoning. J Bacteriol. 183:2001;6207-6214
17. Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.-.M., Lubensky I., Duan D.R., Florence C., Pozzatti R., Walther M.M., Bander N.H., Grossman H.B., Brauch H., Pomer S., Brooks J.D., Isaacs W.B., Lerman M.I., Zbar B., Linehan W.M. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet. 7:1994;85-90
18. Goldberg M.A., Dunning S.P., Bunn H.F. Regulation of the erythropoietin gene. evidence that the oxygen sensor is a heme protein Science. 242:1988;1412-1415
19. Haase V.H., Glickman J.N., Socolovsky M., Jaenisch R. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA. 98:2001;1583-1588
20. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 86:1996;353-364
21. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., Schofield C.J. Hypoxia inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem. 277:2002;26351-26355
22. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem. 278:2003;30772-30780
23. Hon W.C., Wilson M.I., Harlos K., Claridge T.D., Schofield C.J., Pugh C.W., Maxwell P.H., Ratcliffe P.J., Stuart D.I., Jones E.Y. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature. 417:2002;975-978
24. Huang J., Zhao Q., Mooney S.M., Lee F.S. Sequence determinants in hypoxia inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem. 277:2002;39792-39800
25. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily on redox-sensitive stabilization of its α subunit. J Biol Chem. 271:1996;32253-32259
26. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., Kaelin W.G. Jr. Biochemical purification and pharmalogical inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA. 99:2002;13459-13464
27. 2 sensing Science. 292:2001;464-468
28. 2-regulated prolyl hydroxylation. Science. 292:2001;468-472
29. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., Yoo M.A., Song E.J., Lee K.J., Kim K.W. Regulation and Destabilization of HIF-1α by ARD1-Mediated Acetylation. Cell. 111:2002;709-720
30. Kaelin W.G., Maher E.R. The VHL tumor-suppressor gene paradigm. Trends Genet. 14:1998;423-426
31. Knowles H.J., Raval R.R., Harris A.L., Ratcliffe P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63:2003;1764-1768
32. Kondo K., Klco J., Nakamura E., Lechpammer M., Kaelin W.G. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 1:2002;237-246
33. Kuznetsova A.V., Meller J., Schnell P.O., Nash J.A., Ignacak M.L., Sanchez Y., Conaway J.W., Conaway R.C., Czyzyk-Krzeska M.F. Von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc Natl Acad Sci USA. 100:2003;2706-2711
34. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16:2002;1466-1471
35. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain. a hypoxic switch Science. 295:2002;858-861. (Reports)
36. Latif F., Tory K., Gnarra J., Yao M., Duh F.-.M., Orcutt M.L., Stackhouse T., Kuzmin I., Modi W., Geil L., Schmidt L., Zhou F., Li H., Wei M.H., Chen F., Glenn G., Choyke P., Walther M.M., Weng Y., Duan D.-.S.R., Dean M., Glavac D., Richards F.M., Crossey P.A., Ferguson-Smith M.A., Le Paslier D., Chumakov I., Cohen D., Chinault A.C., Maher E.R., Linehan W.M., Zbar B., Lerman M.I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 260:1993;1317-1320
37. Lavista-Llanos S., Centanin L., Irisarri M., Russo D.M., Gleadle J.M., Bocca S.N., Muzzopappa M., Ratcliffe P.J., Wappner P. Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar. Mol Cell Biol. 22:2002;6842-6853
38. Lieb M.E., Menzies K., Moschella M.C., Ni R., Taubman M.B. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation. Biochem Cell Biol. 80:2002;421-426
39. Lipscomb E.A., Sarmiere P.D., Crowder R.J., Freeman R.S. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J Neurochem. 73:1999;429-432
40. Lipscomb E.A., Sarmiere P.D., Freeman R.S. SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J Biol Chem. 276:2001;5085-5092
41. Mack F.A., Rathmell W.K., Arsham A.M., Gnarra J., Keith B., Simon M.C. Loss of pVHL is sufficient to cause HIF dysregulation in primary cells but does not promote tumor growth. Cancer Cell. 3:2003;75-88
42. Mahon P.C., Hirota K., Semenza G.L. FIH-1. a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity Genes Dev. 15:2001;2675-2686
43. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H., Cao Y., Berkenstam A., Poellinger L. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature [letters]. 414:2001;550-554
44. Mandriota S.J., Turner K.J., Davies D.R., Murray P.G., Morgan N.V., Sowter H.M., Wykoff C.C., Maher E.R., Harris A.L., Ratcliffe P.J., Maxwell P.H. HIF activation identifies early lesions in VHL kidneys. Evidence for site-specific tumor suppressor function in the nephron. Cancer Cell. 1:2002;459-468
45. Maranchie J.K., Vasselli J.R., Riss J., Bonifacino J.S., Linehan W.M., Klausner R.D. The contribution of VHL substrate binding and HIF1-α to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell. 1:2002;247-255
46. Masson N., Willam C., Maxwell P.H., Pugh C.W., Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J. 20:2001;5197-5206
47. Maxwell P.H., Dachs G.U., Gleadle J.M., Nicholls L.G., Harris A.L., Stratford I.J., Hankinson O., Pugh C.W., Ratcliffe P.J. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA. 94:1997;8104-8109
48. Maxwell P.H., Osmond M.K., Pugh C.W., Heryet A., Nicholls L.G., Tan C.C., Doe B.G., Ferguson D.J.P., Johnson M.H., Ratcliffe P.J. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int. 44:1993;1149-1162
49. Maxwell P.H., Pugh C.W., Ratcliffe P.J. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines. evidence for a widespread oxygen sensing mechanism Proc Natl Acad Sci USA. 90:1993;2423-2427
50. Maxwell P.H., Pugh C.W., Ratcliffe P.J. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 11:2001;293-299
51. Maxwell P.H., Wiesener M.S., Chang G.-.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275
52. Maynard M.A., Qi H., Chung J., Lee E.H., Kondo Y., Hara S., Conaway R.C., Conaway J.W., Ohh M. Multiple splice variants of the human HIF-3α locus are targets of the VHL E3 ubiquitin ligase complex. J Biol Chem. 278:2003;11032-11040
53. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., Huang W.Q., Wotzlaw C., Hellwig-Burgel T., Jelkmann W., Acker H., Fandrey J. Intracellular localisation of human HIF-1α hydroxylases. implications for oxygen sensing J Cell Sci. 116:2003;1319-1326
54. Min J.H., Yang H., Ivan M., Gertler F., Kaelin W.G. Jr., Pavletich N.P. Structure of an HIF-1α-pVHL complex. hydroxyproline recognition in signaling Science. 296:2002;1886-1889
55. Na X., Duan H.O., Messing E.M., Schoen S.R., Ryan C.K., di Sant'Agnese P.A., Golemis E.A., Wu G. Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein. EMBO J. 22:2003;4249-4259
56. Necas E., Thorling E.B. Unresponsiveness of erythropoietin-producing cells to cyanide. Am J Physiol. 222:1972;1187-1190
57. Oehme F., Ellinghaus P., Kolkhof P., Smith T., Ramakrishnan S., Hutter J., Schramm M., Flamme I. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun. 296:2002;343
58. Plisov S.Y., Ivanov S.V., Yoshino K., Dove L.F., Plisova T.M., Higinbotham K.G., Karavanova I., Lerman M., Perantoni A.O. Mesenchymal- epithelial transition in the developing metanephric kidney. gene expression study by differential display Genesis. 27:2000;22-31
59. Ren X., Dorrington K.L., Maxwell P.H., Robbins P.A. Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans. J Appl Physiol. 89:2000;680-686
60. Richard D.E., Berra E., Gothie E., Roux D., Pouysségur J. P42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J Biol Chem. 274:1999;32631-32637
61. Ryan H.E., Lo J., Johnson R.S. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:1998;3005-3015
62. Ryan H.E., Poloni M., McNulty W., Elson D., Gassmann M., Arbeit J.M., Johnson R.S. Hypoxia-inducible factor-lα is a positive factor in solid tumor growth. Cancer Res. 60:2000;4010-4015
63. Schofield C.J., Zhang Z. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr Opin Struct Biol. 9:1999;722-731
64. Seagroves T.N., Ryan H.E., Lu H., Wouters B.G., Knapp M., Thibault P., Laderoute K., Johnson R.S. Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells. Mol Cell Biol. 21:2001;3436-3444
65. Seth P., Krop I., Porter D., Polyak K. Novel estrogen and tamoxifen induced genes identified by SAGE (Serial Analysis of Gene Expression). Oncogene. 21:2002;836-843
66. Talks K., Turley H., Gatter K.C., Maxwell P.H., Pugh C.W., Ratcliffe P.J., Harris A.L. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 157:2000;411-421
67. Taylor M.S. Characterization and comparative analysis of the EGLN gene family. Gene. 275:2001;125-132
68. Trent C., Tsung N., Horvitz H.R. Egg-laying defective mutants of the nematode Caenorhabditis elegans. Genetics. 104:1983;619-647
69. Turner K.J., Moore J.W., Jones A., Taylor C.F., Cuthbert-Heavens D., Han C., Leek R.D., Gatter K.C., Maxwell P.H., Ratcliffe P.J., Cranston D., Harris A.L. Expression of Hypoxia-inducible Factors in Human Renal Cancer. relationship to angiogenesis and to the von Hippel-Lindau gene mutation Cancer Res. 62:2002;2957-2961
70. Vaux E.C., Metzen E., Yeates K.M., Ratcliffe P.J. Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood. 98:2001;296-302
71. Vaux E.C., Wood S.M., Cockman M.E., Nicholls L.G., Yeates K.M., Pugh C.W., Maxwell P.H., Ratcliffe P.J. Selection of mutant CHO cells with constitutive activation of the HIF system and inactivation of the von Hippel-Lindau tumor suppressor. J Biol Chem. 12:2001;12
72. 2 tension. Proc Natl Acad Sci USA. 92:1995;5510-5514
73. Wang G.L., Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem. 268:1993;21513-21518
74. Wang G.L., Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity. implications for models of hypoxia signal transduction Blood. 82:1993;3610-3615
75. Warburg O. On the origin of cancer cells. Science. 123:1956;309-314
76. Wax S.D., Rosenfield C.L., Taubman M.B. Identification of a novel growth factor-responsive gene in vascular smooth muscle cells. J Biol Chem. 269:1994;13041-13047
77. Wax S.D., Tsao L., Lieb M.E., Fallon J.T., Taubman M.B. SM-20 is a novel 40-kd protein whose expression in the arterial wall is restricted to smooth muscle. Lab Invest. 74:1996;797-808
78. Wenger R.H., Rolfs A., Spielmann P., Zimmermann D.R., Gassmann M. Mouse hypoxia-inducible factor-1α is encoded by two different mRNA isoforms. expression from a tissue-specific and a housekeeping-type promoter Blood. 91:1998;3471-3480
79. Wiesener M.S., Munchenhagen P.M., Berger I., Roigas J., Schwiertz A., Jurgensen J.S., Gruber G., Maxwell P.H., Loning S.A., Frei U., Grone H.J., Eckardt K.U. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res. 61:2000;5215-5222
80. Wiesener M.S., Turley H., Allen W.E., William C., Eckardt K.-.U., Talks K.L., Wood S.M., Gatter K.C., Harris A.L., Pugh C.W., Ratcliffe P.J., Maxwell P.H. Induction of endothelial PAS domain protein-1 by hypoxia. characterization and comparison with hypoxia-inducible factor-1α Blood. 92:1998;2260-2268
81. Willam C., Masson N., Tian Y.M., Mahmood S.A., Wilson M.I., Bicknell R., Eckardt K.U., Maxwell P.H., Ratcliffe P.J., Pugh C.W. Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis. Proc Natl Acad Sci USA. 99:2002;10423-10428
82. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res. 59:1999;5830-5835